KRYS Krystal Biotech, Inc.

NASDAQ
$315.34

Krystal Biotech, Inc. (KRYS) Earnings News

Earnings press releases, previews and reviews for Krystal Biotech, Inc. (KRYS), newest first. Our most recent is review: Krystal Biotech Beats on Vyjuvek Strength and Adds a $400 Million Buyback, but Pipeline Timelines Slip Into 2027.